Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

April 20, 2026

Study Completion Date

April 20, 2027

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

Cadonilimab

Injectable solution

DRUG

Lenvatinib

capsule

Trial Locations (1)

RECRUITING

Hunan Cancer Hospital, Changsha

All Listed Sponsors

lead

Hunan Cancer Hospital

OTHER